Detalles de la búsqueda
1.
The impact of salvage radiotherapy initiation at PSA ≤ 0.5 ng/ml on metastasis-free survival in patients with relapsed prostate cancer following prostatectomy.
Prostate
; 83(2): 190-197, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36316967
2.
Radiating the prostate bed in relapsed oligometastatic prostate cancer: How comprehensive should we be?
Prostate
; 82(5): 551-555, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35014708
3.
A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS).
BMC Cancer
; 20(1): 492, 2020 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32487038
4.
A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA).
BMC Cancer
; 19(1): 572, 2019 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-31196032
5.
Detectable end of radiation prostate specific antigen assists in identifying men with unfavorable intermediate-risk prostate cancer at high risk of distant recurrence and cancer-specific mortality.
Prostate
; 78(8): 623-630, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29520847
6.
Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.
JAMA
; 319(9): 896-905, 2018 03 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29509865
7.
A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE).
BMC Cancer
; 17(1): 453, 2017 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-28662647
8.
Effect of Transperineal Versus Transrectal Prostate Biopsy on the Quality of Hydrogel Spacer Placement in Men Prior to Radiation Therapy for Prostate Cancer.
Urology
; 182: 27-32, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37805052
9.
Improving Quality Metrics in Radiation Oncology: Implementation of Pretreatment Peer Review for Stereotactic Body Radiation Therapy in Patients with Thoracic Cancer.
Adv Radiat Oncol
; 8(2): 101004, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37008272
10.
Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial.
J Clin Oncol
; 41(6): 1307-1317, 2023 02 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36367998
11.
External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis.
Int J Radiat Oncol Biol Phys
; 115(3): 645-653, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36179990
12.
Regulation of colony stimulating factor-1 expression and ovarian cancer cell behavior in vitro by miR-128 and miR-152.
Mol Cancer
; 11: 58, 2012 Aug 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-22909061
13.
Interim analysis of companion, prospective, phase II, clinical trials assessing the efficacy and safety of multi-modal total eradication therapy in men with synchronous oligometastatic prostate cancer.
Med Oncol
; 39(5): 63, 2022 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35478055
14.
Definitions of disease burden across the spectrum of metastatic castration-sensitive prostate cancer: comparison by disease outcomes and genomics.
Prostate Cancer Prostatic Dis
; 25(4): 713-719, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35013522
15.
Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts.
JAMA Oncol
; 8(3): e216871, 2022 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35050303
16.
18F-Fluciclovine-Avid Pulmonary Hamartoma.
Clin Nucl Med
; 46(11): 919-921, 2021 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34582137
17.
Patterns of Recurrence and Modes of Progression After Metastasis-Directed Therapy in Oligometastatic Castration-Sensitive Prostate Cancer.
Int J Radiat Oncol Biol Phys
; 109(2): 387-395, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32798608
18.
Metastasis-directed Therapy Prolongs Efficacy of Systemic Therapy and Improves Clinical Outcomes in Oligoprogressive Castration-resistant Prostate Cancer.
Eur Urol Oncol
; 4(3): 447-455, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32536574
19.
Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer.
JAMA Netw Open
; 4(12): e2138550, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34902034
20.
Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features.
JAMA Netw Open
; 4(7): e2115312, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34196715